The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lungs in Vitro Model Market Research Report 2024
Synopsis
Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
The global Lungs in Vitro Model market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lungs in Vitro Model is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lungs in Vitro Model is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lungs in Vitro Model in Drug Discovery and Toxicology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lungs in Vitro Model include ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero and Cn Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lungs in Vitro Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lungs in Vitro Model.
Report Scope
The Lungs in Vitro Model market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lungs in Vitro Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lungs in Vitro Model companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
AlveoliX
Oncotheis
Segment by Type
2D Cell Models
3D Cell Models
Segment by Application
Drug Discovery and Toxicology
3D Model Development
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lungs in Vitro Model companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
The global Lungs in Vitro Model market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lungs in Vitro Model is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lungs in Vitro Model is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lungs in Vitro Model in Drug Discovery and Toxicology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lungs in Vitro Model include ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero and Cn Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lungs in Vitro Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lungs in Vitro Model.
Report Scope
The Lungs in Vitro Model market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lungs in Vitro Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lungs in Vitro Model companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
AlveoliX
Oncotheis
Segment by Type
2D Cell Models
3D Cell Models
Segment by Application
Drug Discovery and Toxicology
3D Model Development
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lungs in Vitro Model companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lungs in Vitro Model Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 2D Cell Models
1.2.3 3D Cell Models
1.3 Market by Application
1.3.1 Global Lungs in Vitro Model Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Toxicology
1.3.3 3D Model Development
1.3.4 Basic Research
1.3.5 Physiological Research
1.3.6 Stem Cell Research and Regenerative Medicine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lungs in Vitro Model Market Perspective (2019-2030)
2.2 Lungs in Vitro Model Growth Trends by Region
2.2.1 Global Lungs in Vitro Model Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lungs in Vitro Model Historic Market Size by Region (2019-2024)
2.2.3 Lungs in Vitro Model Forecasted Market Size by Region (2025-2030)
2.3 Lungs in Vitro Model Market Dynamics
2.3.1 Lungs in Vitro Model Industry Trends
2.3.2 Lungs in Vitro Model Market Drivers
2.3.3 Lungs in Vitro Model Market Challenges
2.3.4 Lungs in Vitro Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lungs in Vitro Model Players by Revenue
3.1.1 Global Top Lungs in Vitro Model Players by Revenue (2019-2024)
3.1.2 Global Lungs in Vitro Model Revenue Market Share by Players (2019-2024)
3.2 Global Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lungs in Vitro Model Revenue
3.4 Global Lungs in Vitro Model Market Concentration Ratio
3.4.1 Global Lungs in Vitro Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Model Revenue in 2023
3.5 Lungs in Vitro Model Key Players Head office and Area Served
3.6 Key Players Lungs in Vitro Model Product Solution and Service
3.7 Date of Enter into Lungs in Vitro Model Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lungs in Vitro Model Breakdown Data by Type
4.1 Global Lungs in Vitro Model Historic Market Size by Type (2019-2024)
4.2 Global Lungs in Vitro Model Forecasted Market Size by Type (2025-2030)
5 Lungs in Vitro Model Breakdown Data by Application
5.1 Global Lungs in Vitro Model Historic Market Size by Application (2019-2024)
5.2 Global Lungs in Vitro Model Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lungs in Vitro Model Market Size (2019-2030)
6.2 North America Lungs in Vitro Model Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lungs in Vitro Model Market Size by Country (2019-2024)
6.4 North America Lungs in Vitro Model Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lungs in Vitro Model Market Size (2019-2030)
7.2 Europe Lungs in Vitro Model Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lungs in Vitro Model Market Size by Country (2019-2024)
7.4 Europe Lungs in Vitro Model Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lungs in Vitro Model Market Size (2019-2030)
8.2 Asia-Pacific Lungs in Vitro Model Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lungs in Vitro Model Market Size by Region (2019-2024)
8.4 Asia-Pacific Lungs in Vitro Model Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lungs in Vitro Model Market Size (2019-2030)
9.2 Latin America Lungs in Vitro Model Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lungs in Vitro Model Market Size by Country (2019-2024)
9.4 Latin America Lungs in Vitro Model Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lungs in Vitro Model Market Size (2019-2030)
10.2 Middle East & Africa Lungs in Vitro Model Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lungs in Vitro Model Market Size by Country (2019-2024)
10.4 Middle East & Africa Lungs in Vitro Model Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ATCC
11.1.1 ATCC Company Detail
11.1.2 ATCC Business Overview
11.1.3 ATCC Lungs in Vitro Model Introduction
11.1.4 ATCC Revenue in Lungs in Vitro Model Business (2019-2024)
11.1.5 ATCC Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Lungs in Vitro Model Introduction
11.2.4 Lonza Revenue in Lungs in Vitro Model Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Epithelix
11.3.1 Epithelix Company Detail
11.3.2 Epithelix Business Overview
11.3.3 Epithelix Lungs in Vitro Model Introduction
11.3.4 Epithelix Revenue in Lungs in Vitro Model Business (2019-2024)
11.3.5 Epithelix Recent Development
11.4 Mattek
11.4.1 Mattek Company Detail
11.4.2 Mattek Business Overview
11.4.3 Mattek Lungs in Vitro Model Introduction
11.4.4 Mattek Revenue in Lungs in Vitro Model Business (2019-2024)
11.4.5 Mattek Recent Development
11.5 Emulate
11.5.1 Emulate Company Detail
11.5.2 Emulate Business Overview
11.5.3 Emulate Lungs in Vitro Model Introduction
11.5.4 Emulate Revenue in Lungs in Vitro Model Business (2019-2024)
11.5.5 Emulate Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Lungs in Vitro Model Introduction
11.6.4 Mimetas Revenue in Lungs in Vitro Model Business (2019-2024)
11.6.5 Mimetas Recent Development
11.7 Tissuse
11.7.1 Tissuse Company Detail
11.7.2 Tissuse Business Overview
11.7.3 Tissuse Lungs in Vitro Model Introduction
11.7.4 Tissuse Revenue in Lungs in Vitro Model Business (2019-2024)
11.7.5 Tissuse Recent Development
11.8 Insphero
11.8.1 Insphero Company Detail
11.8.2 Insphero Business Overview
11.8.3 Insphero Lungs in Vitro Model Introduction
11.8.4 Insphero Revenue in Lungs in Vitro Model Business (2019-2024)
11.8.5 Insphero Recent Development
11.9 Cn Bio
11.9.1 Cn Bio Company Detail
11.9.2 Cn Bio Business Overview
11.9.3 Cn Bio Lungs in Vitro Model Introduction
11.9.4 Cn Bio Revenue in Lungs in Vitro Model Business (2019-2024)
11.9.5 Cn Bio Recent Development
11.10 AlveoliX
11.10.1 AlveoliX Company Detail
11.10.2 AlveoliX Business Overview
11.10.3 AlveoliX Lungs in Vitro Model Introduction
11.10.4 AlveoliX Revenue in Lungs in Vitro Model Business (2019-2024)
11.10.5 AlveoliX Recent Development
11.11 Oncotheis
11.11.1 Oncotheis Company Detail
11.11.2 Oncotheis Business Overview
11.11.3 Oncotheis Lungs in Vitro Model Introduction
11.11.4 Oncotheis Revenue in Lungs in Vitro Model Business (2019-2024)
11.11.5 Oncotheis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
